Aurora Cannabis (ACB) Profit After Tax (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Profit After Tax of -$27.6 million for Q1 2026, down 127.29% year-over-year from $101.0 million in Q1 2025, and down 536.38% quarter-over-quarter from $6.3 million in Q4 2025.
Aurora Cannabis (ACB) Profit After Tax (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Profit After Tax for 10 consecutive years, with -$27.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 127.29% year-over-year to -$27.6 million; the TTM figure through Mar 2026 stood at -$73.9 million (down 738.51% YoY), while the FY2026 annual figure was -$42.7 million, down 258.02% from the prior year.
- Profit After Tax eased to -$27.6 million in Q1 2026 per ACB's latest filing, from $6.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $20.1 million in Q4 2024 and bottomed at -$4.7 billion in Q2 2023.
- Historically, Profit After Tax has averaged -$445.9 million across 5 years, with a median of -$17.1 million in 2024.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 5346.9% — and 2024, when it jumped 260.6%.
- Aurora Cannabis' Profit After Tax stood at -$530.2 million in 2022, then surged by 97.64% to -$12.5 million in 2023, then surged by 260.6% to $20.1 million in 2024, then tumbled by 68.61% to $6.3 million in 2025, then sank by 536.38% to -$27.6 million in 2026.
- Business Quant data shows ACB's Profit After Tax at -$27.6 million in Q1 2026, $6.3 million in Q4 2025, and -$38.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aurora Cannabis | 233.15 Mn | 160.83 Mn | 25.75 Mn | -2.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.57 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Sep 30, 2025 | -38.63 Mn |
| Jun 30, 2025 | -13.99 Mn |
| Mar 31, 2025 | -12.13 Mn |
| Dec 31, 2024 | 20.12 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -20.27 Mn |
| Dec 31, 2023 | -12.53 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -4.71 Bn |
| Dec 31, 2022 | -530.22 Mn |
| Sep 30, 2022 | -514.23 Mn |
| Jun 30, 2022 | -483.95 Mn |
| Mar 31, 2022 | -799.09 Mn |
| Dec 31, 2021 | -59.61 Mn |
| Sep 30, 2021 | -9.44 Mn |
| Jun 30, 2021 | -108.99 Mn |
| Mar 31, 2021 | -130.09 Mn |